BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24772329)

  • 1. The Role of Dihydroorotate Dehydrogenase in Apoptosis Induction in Response to Inhibition of the Mitochondrial Respiratory Chain Complex III.
    Khutornenko AA; Dalina AA; Chernyak BV; Chumakov PM; Evstafieva AG
    Acta Naturae; 2014 Jan; 6(1):69-75. PubMed ID: 24772329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway.
    Khutornenko AA; Roudko VV; Chernyak BV; Vartapetian AB; Chumakov PM; Evstafieva AG
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):12828-33. PubMed ID: 20566882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydro-orotate dehydrogenase is physically associated with the respiratory complex and its loss leads to mitochondrial dysfunction.
    Fang J; Uchiumi T; Yagi M; Matsumoto S; Amamoto R; Takazaki S; Yamaza H; Nonaka K; Kang D
    Biosci Rep; 2013 Feb; 33(2):e00021. PubMed ID: 23216091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mitochondrial complex III or dihydroorotate dehydrogenase (DHODH) triggers formation of poly(A)
    Miyake S; Masuda S
    RNA Biol; 2022 Jan; 19(1):1244-1255. PubMed ID: 36412986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sustained deficiency of mitochondrial respiratory complex III induces an apoptotic cell death through the p53-mediated inhibition of pro-survival activities of the activating transcription factor 4.
    Evstafieva AG; Garaeva AA; Khutornenko AA; Klepikova AV; Logacheva MD; Penin AA; Novakovsky GE; Kovaleva IE; Chumakov PM
    Cell Death Dis; 2014 Nov; 5(11):e1511. PubMed ID: 25375376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DHODH and cancer: promising prospects to be explored.
    Zhou Y; Tao L; Zhou X; Zuo Z; Gong J; Liu X; Zhou Y; Liu C; Sang N; Liu H; Zou J; Gou K; Yang X; Zhao Y
    Cancer Metab; 2021 May; 9(1):22. PubMed ID: 33971967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Dihydroorotate Dehydrogenase Inhibitors Using the Cell Painting Assay.
    Schölermann B; Bonowski J; Grigalunas M; Burhop A; Xie Y; Hoock JGF; Liu J; Dow M; Nelson A; Nowak C; Pahl A; Sievers S; Ziegler S
    Chembiochem; 2022 Nov; 23(22):e202200475. PubMed ID: 36134475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Warburg effect modulates DHODH role in ferroptosis: a review.
    Amos A; Amos A; Wu L; Xia H
    Cell Commun Signal; 2023 May; 21(1):100. PubMed ID: 37147673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroorotate dehydrogenase is required for N-(4-hydroxyphenyl)retinamide-induced reactive oxygen species production and apoptosis.
    Hail N; Chen P; Kepa JJ; Bushman LR; Shearn C
    Free Radic Biol Med; 2010 Jul; 49(1):109-16. PubMed ID: 20399851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroorotate dehydrogenase (DHODH) inhibitors affect ATP depletion, endogenous ROS and mediate S-phase arrest in breast cancer cells.
    Mohamad Fairus AK; Choudhary B; Hosahalli S; Kavitha N; Shatrah O
    Biochimie; 2017 Apr; 135():154-163. PubMed ID: 28196676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial-Linked
    Peeters MJW; Aehnlich P; Pizzella A; Mølgaard K; Seremet T; Met Ö; Rasmussen LJ; Thor Straten P; Desler C
    Front Immunol; 2021; 12():718863. PubMed ID: 34899685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DHODH inhibition modulates glucose metabolism and circulating GDF15, and improves metabolic balance.
    Zhang J; Terán G; Popa M; Madapura H; Ladds MJGW; Lianoudaki D; Grünler J; Arsenian-Henriksson M; McCormack E; Rottenberg ME; Catrina SB; Laín S; Darekar S
    iScience; 2021 May; 24(5):102494. PubMed ID: 34113829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis.
    He T; Haapa-Paananen S; Kaminskyy VO; Kohonen P; Fey V; Zhivotovsky B; Kallioniemi O; Perälä M
    Oncogene; 2014 Jul; 33(27):3538-49. PubMed ID: 24013224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydroorotate dehydrogenase in oxidative phosphorylation and cancer.
    Boukalova S; Hubackova S; Milosevic M; Ezrova Z; Neuzil J; Rohlena J
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165759. PubMed ID: 32151633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mitochondrial complex III induces differentiation in acute myeloid leukemia.
    Zhang Y; Luo T; Ding X; Chang Y; Liu C; Zhang Y; Hao S; Yin Q; Jiang B
    Biochem Biophys Res Commun; 2021 Apr; 547():162-168. PubMed ID: 33610916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathway to pyrimidines: The essential focus on dihydroorotate dehydrogenase, the mitochondrial enzyme coupled to the respiratory chain.
    Löffler M; Carrey EA; Knecht W
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1281-1305. PubMed ID: 32043431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects.
    Klotz L; Eschborn M; Lindner M; Liebmann M; Herold M; Janoschka C; Torres Garrido B; Schulte-Mecklenbeck A; Gross CC; Breuer J; Hundehege P; Posevitz V; Pignolet B; Nebel G; Glander S; Freise N; Austermann J; Wirth T; Campbell GR; Schneider-Hohendorf T; Eveslage M; Brassat D; Schwab N; Loser K; Roth J; Busch KB; Stoll M; Mahad DJ; Meuth SG; Turner T; Bar-Or A; Wiendl H
    Sci Transl Med; 2019 May; 11(490):. PubMed ID: 31043571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacology.
    Ladds MJGW; Popova G; Pastor-Fernández A; Kannan S; van Leeuwen IMM; Håkansson M; Walse B; Tholander F; Bhatia R; Verma CS; Lane DP; Laín S
    J Biol Chem; 2020 Dec; 295(52):17935-17949. PubMed ID: 32900849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer.
    Madak JT; Bankhead A; Cuthbertson CR; Showalter HD; Neamati N
    Pharmacol Ther; 2019 Mar; 195():111-131. PubMed ID: 30347213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence supporting a role for dihydroorotate dehydrogenase, bioenergetics, and p53 in selective teriflunomide-induced apoptosis in transformed versus normal human keratinocytes.
    Hail N; Chen P; Kepa JJ; Bushman LR
    Apoptosis; 2012 Mar; 17(3):258-68. PubMed ID: 22012334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.